Drugs / BREMEN eye drops
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03235232 | Feb 2021 → Jul 2023 | ocular hypertension, open-angle glaucoma | EMS | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BREMEN eye drops | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03235232 ↗ |
| Route | Topical | “1 drop in the affected eye(s), twice a day (approximately each 12 hours) for 8 weeks.” NCT03235232 ↗ |